TBIO OTC
Telesis Bio, Inc.
1W: -99.1%
1M: -90.0%
3M: -99.8%
YTD: -99.8%
1Y: -99.2%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$28M
+0.3% ▲
5Y CAGR: +80.9%
Gross Profit
$17M
+8.7% ▲
5Y CAGR: +64.2%
Operating Income
-$47M
-0.1% ▼
Net Income
-$48M
+1.5% ▲
EPS (Diluted)
$-1.59
+3.6% ▲
EBITDA
-$40M
+7.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $5M | $7M | $11M | $27M | $28M |
| YoY Growth | +238.4% | +36.9% | +67.9% | +148.4% | +0.3% |
| Cost of Revenue | $9M | $3M | $7M | $12M | $11M |
| Gross Profit | -$4M | $4M | $4M | $16M | $17M |
| Gross Margin | -85.0% | 55.1% | 38.9% | 56.8% | 61.6% |
| R&D Expenses | $1M | $9M | $15M | $23M | $17M |
| SG&A Expenses | $2M | $11M | $25M | $39M | $35M |
| Operating Expenses | $3M | $20M | $40M | $62M | $63M |
| Operating Income | -$7M | -$16M | -$35M | -$46M | -$47M |
| Operating Margin | -145.2% | -248.8% | -320.3% | -169.4% | -169.2% |
| Interest Expense | $1M | $690K | $1M | $2M | $3M |
| Income Before Tax | -$8M | -$18M | -$39M | -$48M | -$48M |
| Tax Expense | $0 | $5K | $14K | $24K | $24K |
| Net Income | -$8M | -$18M | -$39M | -$48M | -$48M |
| Net Margin | -172.8% | -273.9% | -352.8% | -176.7% | -173.5% |
| EPS (Diluted) | $-0.20 | $-0.62 | $-1.33 | $-1.65 | $-1.59 |
| EBITDA | -$6M | -$16M | -$36M | -$44M | -$40M |
| Shares Outstanding | 41M | 29M | 29M | 29M | 30M |